Hooper Holmes Appoints Dr. Neil Gordon Corporate Medical Director
03 February 2015 - 1:00AM
Business Wire
Hooper Holmes (NYSE MKT:HH) has appointed a medical director
with deep experience in evidence-based wellness programs to expand
the Company’s biometric screening capabilities and develop new
services.
Dr. Neil F. Gordon, M.D., PhD, MPH, FACC, will oversee the
medical content of Hooper’s screening programs and further improve
the participant experience. He will help develop new services that
draw upon his expertise in lifestyle management and chronic disease
risk reduction, as well as upon the capabilities of Clinical
Reference laboratory, Inc. (CRL), the Company’s strategic partner
for laboratory testing services.
Henry E. Dubois, President and CEO of Hooper Holmes, commented,
“Dr. Gordon’s appointment expands our medical domain expertise and
will help customers motivate and engage their program participants.
He will play a leadership role on our team as we continue to
develop new services.”
Dr. Gordon has served as medical director for several corporate
wellness providers and as a Clinical Professor of Medicine at the
Emory University School of Medicine. He has also served as Vice
President of the American Association for Cardiovascular and
Pulmonary Rehabilitation, as a member of the Board of Trustees of
the American College of Sports Medicine, and as Chairman of the
American Heart Association Committee on Exercise, Cardiac
Rehabilitation and Prevention.
Dr. Neil Gordon commented, “My career has been devoted to
preventing cardiovascular disease and other chronic illnesses.
Corporate wellness programs and clinical research have important
roles to play in these efforts. Hooper is an acknowledged leader in
biometric screenings for groups of any size and I am delighted to
help Hooper and its customers change behavior, reduce risk and
deliver measurable results.”
In 1997, Dr. Gordon became founder, CEO and chief science
officer of INTERVENT USA, a provider of evidence-based, lifestyle
management and chronic disease risk reduction services, which was
acquired by Nationwide Better Health in April 2007. Dr. Gordon
served as chief medical and science officer of Nationwide Better
Health until 2011 when, under his leadership, INTERVENT
International and its affiliate companies reacquired global rights.
His role as CEO and chief science officer of INTERVENT
International continues.
Dr. Gordon has served as principal investigator for research
grants funded by the American Heart Association, the National
Institutes of Health, and the American Diabetes Association. He is
the author of eight books on preventive medicine and more than 100
scientific articles in peer-reviewed medical journals including the
American Journal of Cardiology, British Heart Journal, Circulation,
Journal of the American College of Cardiology, and the Journal of
the American Medical Association. Dr. Gordon obtained his M.D. and
a Ph.D. in exercise physiology in Johannesburg, South Africa,
before relocating to the United States in 1987. He received his
master’s degree in public health from the University of California,
Los Angeles.
About Hooper Holmes
Hooper Holmes, Inc. mobilizes a national network of health
professionals to provide on-site health screenings, laboratory
testing, risk assessment and sample collection services to wellness
and disease management companies, insurance companies, employers,
government organizations and academic institutions.
This press release contains “forward-looking” statements; as
such term is defined in the Private Securities Litigation Reform
Act of 1995. These forward-looking statements are based on the
Company’s current expectations and beliefs and are subject to a
number of risks, uncertainties and assumptions. Among the important
factors that could cause actual results to differ materially from
those expressed in, or implied by, these forward-looking statements
are our ability to realize the expected benefits from our strategic
alliance with Clinical Reference Laboratory; our ability to
successfully implement our business strategy; our ability to retain
and grow our customer base; our ability to recognize operational
efficiencies and reduce costs; uncertainty as to our working
capital requirements over the next 12 to 24 months; our ability to
maintain compliance with the financial covenant in our credit
facility; and the rate of growth in the Health and Wellness market.
Additional information about these and other factors that could
affect the Company’s business is set forth in the Company’s annual
report on Form 10-K for the year ended December 31, 2013, filed
with the Securities and Exchange Commission on March 31, 2014. The
Company undertakes no obligation to update or release any revisions
to these forward-looking statements to reflect events or
circumstances after the date of this press release to reflect the
occurrence of unanticipated events, except as required by law.
Hooper HolmesHenry E. Dubois, President and CEO,
913-764-1045orInvestors:S.M. Berger & CompanyAndrew Berger,
216-464-6400